• Culture, Pleural Fluid
  • Hereditary Hemorrhagic Telangiectasia, Gene Mutation Panel
  • MAML2 (11q21) Rearrangement, Mucoepidermoid Carcinoma (MEC), FISH, Tissue
  • Transferrin Receptor, Soluble
  • Lysosomal Acid Lipase, Enzyme Activity
  • Nordiazepam, Urine
  • C1 Esterase Inhibitor, Functional Assay
  • Coagulation Factor VIII Inhibitor Screen, Plasma
  • Ehrlichia and Anaplasma Blood Smear
  • Coagulation Factor VII Activity Assay, Plasma
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

ICD10
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.